162 results on '"Buijs, Arjan"'
Search Results
2. A survey of undetected, clinically relevant chromosome abnormalities when replacing postnatal karyotyping by Whole Genome Sequencing
3. Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing
4. Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion
5. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia
6. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia
7. A neonate with a unique non‐Down syndrome transient proliferative megakaryoblastic disease
8. Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS
9. Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing
10. Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS
11. Sequential cancer mutations in cultured human intestinal stem cells
12. Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma
13. A girl with an atypical form of ataxia telangiectasia and an additional de novo 3.14 Mb microduplication in region 19q12
14. Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS
15. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
16. Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes
17. Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels By Recurrent CTCF inactivating Mutations in T Cell Acute Lymphoblastic Leukemia
18. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification
19. Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy
20. Elevated Enhancer-Oncogene Contacts and Higher Oncogene Expression Levels by Recurrent CTCF Inactivating Mutations in Acute T Cell Leukemia
21. The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription
22. A survey of undetected, clinically relevant chromosome abnormalities when replacing postnatal karyotyping by Whole Genome Sequencing
23. Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia
24. Lethal neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3’ MECOM
25. Lethal neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3’ MECOM
26. A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies
27. Lethal neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3′ MECOM
28. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease
29. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease
30. Lymphoblastic lymphoma with a triple-hit profile: a rare but distinct and relevant entity
31. Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma : long-term follow-up in a single institution
32. Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution
33. A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment
34. High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
35. A neonate with a unique non‐Down syndrome transient proliferative megakaryoblastic disease
36. Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution
37. Sequential cancer mutations in cultured human intestinal stem cells
38. Paired Analyses of Diagnostic and Relapse Samples of MLL rearranged Infant Acute Lymphoblastic Leukemia Reveals Potential Therapy-Resistant Genomic Alterations
39. Constitutional RUNX1 deletion presenting as non-syndromic thrombocytopenia with myelodysplasia: 21q22 ITSN1 as a candidate gene in mental retardation
40. Relation Between Cereblon Expression and Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Thalidomide
41. Novel Bone Marrow Failure Syndrome Due to a Deletion of the EVI1/Mecom Gene.
42. A girl with an atypical form of ataxia telangiectasia and an additional de novo 3.14Mb microduplication in region 19q12
43. A New Pathogenomic Mechanism In FPD/AML by a Constitutional T(16;21) Involving 16p13 ATF7IP2 and 21q22 RUNX1 Loci
44. Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia
45. A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review
46. Simultaneous Analysis of Multiple Chromosomal Aberrations in Chronic Lymphocytic Leukemia (CLL) by Multiplex Ligation-Dependent Probe Amplification (MLPA).
47. Philadelphia chromosome of a constitutional der(22)t(Y;22)(q11.2;p11) with a variant t(1;9;22)(p36;q34;q11) in a case of chronic myelogenous leukemia
48. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCFinactivating mutations in acute T cell leukemia
49. The MN1-TEL Fusion Protein, Encoded by the Translocation (12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor with Transforming Activity
50. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.